Two Sigma Investments
TFFP

Two Sigma Investments’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Two Sigma Investments’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-440
Closed -$7.54K – 3342
2023
Q1 		$7.54K Sell
440
-1,838
-81% -$39.8K ﹤0.01% 2901
2022
Q4 		$59.8K Buy
+2,278
New +$108K ﹤0.01% 2572
2021
Q4 		– Sell
-1,856
Closed -$358K – 5011
2021
Q3 		$358K Sell
1,856
-1,915
-51% -$406K ﹤0.01% 3528
2021
Q2 		$906K Buy
+3,771
New +$1.03M ﹤0.01% 2567

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's TFFP Position: Q2 2023 in Review

Two Sigma Investments sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2023, closing a stake of 440 shares — an estimated $7.54K sold.

Two Sigma Investments first reported a position in TFFP in Q2 2021 and held it in 4 quarters. The position peaked at $906K in Q2 2021. 33 funds tracked by Wall St. Rank hold TFFP as of Q2 2023.

  • Two Sigma Investments reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 440 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $7.54K.
  • Two Sigma Investments first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Two Sigma Investments's TFF Pharmaceuticals, Inc. Common Stock position peaked at $906K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.